id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3329254,d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80,Q1,GOVERNMENT SOLUTIONS LLC,401103251,"OTSUKA AMERICA PHARMACEUTICAL, INC.",2025,first_quarter,HCR,"Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-06T18:03:19-04:00
3530116,d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80,Q1,GOVERNMENT SOLUTIONS LLC,401103251,"OTSUKA AMERICA PHARMACEUTICAL, INC.",2025,first_quarter,HCR,"Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-06T18:03:19-04:00
3601321,d6b8d5b9-9d3f-4e10-9d00-3a2d07b60e80,Q1,GOVERNMENT SOLUTIONS LLC,401103251,"OTSUKA AMERICA PHARMACEUTICAL, INC.",2025,first_quarter,HCR,"Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically, health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2025-04-06T18:03:19-04:00